Containment Systems in Pharma Manufacturing (OEB Levels Explained)

Pharmaceutical manufacturing often involves handling potent active pharmaceutical ingredients (APIs) that can pose health risks to operators if exposure is not properly controlled. To ensure operator safety, product protection, and regulatory compliance, modern pharmaceutical facilities use containment systems.

Containment systems are designed to prevent the escape of hazardous powders, dust, or vapors into the production environment, ensuring safe handling of potent compounds during manufacturing processes such as granulation, blending, milling, and tablet compression.

What is a Containment System?

A containment system in pharmaceutical manufacturing is an engineered solution used to control and limit operator exposure to potent drug substances.

Containment systems typically include:

• Containment isolators
• Closed transfer systems
• High-efficiency filtration systems
• Negative pressure environments
• Barrier technologies

These systems help protect operators, products, and the surrounding environment during manufacturing operations.

Why Containment is Important in Pharmaceutical Manufacturing?

The pharmaceutical industry increasingly develops highly potent compounds that require strict exposure control.

Containment systems help achieve:

• Operator safety when handling potent APIs
• Prevention of cross-contamination between products
• Compliance with GMP and regulatory guidelines
• Controlled and safe manufacturing environments

Without proper containment, airborne particles of potent compounds could create serious occupational health risks.

What are OEB Levels?

To classify the level of containment required, pharmaceutical compounds are categorized using Occupational Exposure Bands (OEB).

OEB levels define the maximum allowable airborne exposure concentration of a compound and help determine the containment strategy required during manufacturing.

Typically, OEB levels range from OEB 1 to OEB 5, with higher levels requiring stronger containment controls.

OEB Levels

OEB 1 – Low Hazard

• Compounds with very low toxicity
• Standard pharmaceutical manufacturing controls are usually sufficient
• Minimal containment measures required

OEB 2 – Moderate Hazard

• Compounds with moderate toxicity
• Basic containment measures and good ventilation are required
• Standard PPE may be sufficient

OEB 3 – Controlled Exposure

• Potent compounds requiring enhanced containment
• Use of closed handling systems and improved dust control
• Controlled material transfer is often necessary

OEB 4 – High Potency

• Highly potent compounds that require advanced containment systems
• Use of isolators, glove boxes, and contained transfer systems
• Strict operator protection measures are required

OEB 5 – Very High Potency

• Extremely potent compounds with very low exposure limits
• Requires fully contained manufacturing environments
• Advanced isolator technology and high containment equipment are essential

Common Containment Technologies in Pharma Manufacturing

Several technologies are used to maintain containment during pharmaceutical processing.

1. Containment Isolators: Isolators provide a fully enclosed barrier system that separates operators from potent materials while allowing controlled handling through glove ports.

2. Split Butterfly Valves: These valves allow contained transfer of powders between equipment without releasing dust into the environment.

3. Closed Transfer Systems: Closed systems allow materials to move between equipment without direct exposure to the surrounding environment.

Common product categories requiring containment include:

• Oncology Drugs
• Hormonal Drugs
• Highly Potent APIs
• Highly Active Small Molecule Drugs

Benefits of Containment Systems

• Improved operator safety
• Reduced cross-contamination risk
• Compliance with GMP and regulatory guidelines
• Better process control and environmental protection
• Safe handling of high-potency compounds

Containment systems play a critical role in modern pharmaceutical manufacturing, especially as the industry continues to develop high-potency drug compounds. Understanding OEB levels and appropriate containment technologies helps manufacturers ensure safe and compliant production environments.

With 35+ years of experience in pharmaceutical process equipment, Anish Pharma Equip Pvt. Ltd. provides containment-ready solutions that help manufacturers handle potent compounds safely while maintaining efficient and GMP-compliant pharmaceutical production.